Notas del episodio
Featuring
Jeffrey Tyner
Professor, Oregon Health & Science University
Principle Investigator, ARTNet AML U54 Center
Dr. Tyner is a leading researcher in cancer biology and therapeutic resistance, with a focus on acute myeloid leukemia (AML), functional precision oncology, and mechanisms of acquired resistance to targeted therapies.
Hosted by
David Goodrich
Professor, Roswell Park Comprehensive Cancer Center
ARTNet Coordinating and Data Management Center
Dr. Goodrich leads discussions exploring the science, collaboration, and translational impact of cancer resistance research across the…

